Litcius/Paper detail

Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases

Maria Grazia Martina, Carmine Giorgio, Marika Allodi, Simone Palese, Elisabetta Barocelli, Vigilio Ballabeni, Martyna Szpakowska, Andy Chevigné, Jan Piet van Hamburg, Nadine Davelaar, Erik Lubberts, Simona Bertoni, Marco Radi

2022European Journal of Medicinal Chemistry31 citationsDOI

Topics & Concepts

C-C chemokine receptor type 6CCL20ChemistryImmune systemIn silicoDrug discoveryPharmacologyImmunologyChemokineMedicineChemokine receptorBiochemistryGeneInflammatory Bowel DiseaseChemokine receptors and signalingImmunotherapy and Immune Responses
Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases | Litcius